Subscribe To

Price Alert Latest News Economic Calendar News

DYAI / Dyadic to Present at World Vaccine Congress Washington 2023

JUPITER, Fla., March 30, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, today announced that its Chief Executive Officer, Mark Emalfarb will be presenting at the upcoming World Vaccine Congress in Washington, D.C. Read More

Demo Live Account See Partner Details

Content Topics

Dyadic

Present

World

Vaccine

Congress

Washington

2023

Stock

DYAI

Posted: Mar 30 2023, 08:30

Author Name: GlobeNewsWire

DYAI News

By GlobeNewsWire
September 29, 2023

Dyadic to Present at Industry and Investor Events in October

JUPITER, Fla., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnolo

By GlobeNewsWire
September 12, 2023

Dyadic to Present at BioProcess International

JUPITER, Fla., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnolo

By Seeking Alpha
August 9, 2023

Dyadic International, Inc. (DYAI) Q2 2023 Earnings Call Transcript

Dyadic International, Inc. (NASDAQ:DYAI ) Q2 2023 Earnings Conference Call August 9, 2023 5:00 PM ET Company Participants Ping Rawson - Chief Financia

By GlobeNewsWire
July 26, 2023

Dyadic to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023

JUPITER, Fla., July 26, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDA

By Seeking Alpha
May 10, 2023

Dyadic International, Inc. (DYAI) Q1 2023 Earnings Call Transcript

Dyadic International, Inc. (NASDAQ:DYAI ) Q1 2023 Earnings Conference Call May 10, 2023 5:00 PM ET Company Participants Ping Rawson - Chief Financial

By Proactive Investors
March 30, 2023

Dyadic reports 21.9% revenue rise, $12.7M in cash for full year 2022 as it rapidly advances technology

Dyadic International Inc (NASDAQ:DYAI) posted its financial results for the year ended 2022 with revenue surging 21.9% year-over-year on the back of

By GlobeNewsWire
March 30, 2023

Dyadic to Present at World Vaccine Congress Washington 2023

JUPITER, Fla., March 30, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnolo

By Seeking Alpha
March 29, 2023

Dyadic International, Inc. (DYAI) Q4 2022 Earnings Call Transcript

Dyadic International, Inc. (NASDAQ:DYAI ) Q4 2022 Results Conference Call March 29, 2023 5:00 PM ET Company Participants Ping Rawson - Chief Financial

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.